glp-1 drugs adverse effects GI of Glucagon-Like Peptide-1 Receptor Agonists Struggling with GLP-1 therapy side
Description
Case 4: After a sleeve gastrectomy, a female patient with type 2 diabetes mellitus discontinued tirzepatide 7.5 mg as advised but resumed it independently due to rising fasting blood glucose levels
doi: 10.1111/j.1463-1326.2012.01567.x
References Kalyvas A, Neromyliotis E, Koutsarnakis C, Komaitis S, Drosos E, Skandalakis G et al
[DOI] [PubMed] [Google Scholar] 58.Frssing S., Nylander M., Chabanova E., Frystyk J., Holst J.J., Kistorp C., Skouby S.O., Faber J
Single-receptor activation triggers these compensatory responses
